← Evidence map

ArticlePharmaceutics2022

Acceptability of Multiparticulate Dosing Using Sympfiny

Kate Abeln et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 36432715